Single domain antibodies, recombinant variable heavy domains derived from the unique heavy-chain only antibodies found in camelids and sharks, are exceptionally rugged due to their ability to refold following heat or chemical denaturation. In addition, a number of single domain antibodies have been found to possess high melting points which provide an even greater degree of stability; one of these, llama-derived A3, is a binder of Staphylococcal enterotoxin B and has a T m of 83.58 8 8 8 8C. In this work, we utilized random mutagenesis and stringent selection in an effort to obtain variants of A3 with even higher melting points. This effort resulted in the selection of a double mutant, A3-T28I-S72I, which has a melting point of 90.08 8 8 8 8C and near wild-type affinity for the target antigen. We further characterized the mutations individually to determine that while both contributed to the thermal stabilization, the T28I mutation accounted for ∼4.18 8 8 8 8C of the 6.58 8 8 8 8C increase. This work demonstrates that by the addition of relatively subtle changes it is possible to further improve the melting temperature of single domain antibodies that are already remarkably stable.
Introduction
Single domain antibodies (sdAbs) derived from camelids and sharks have been widely studied due to desirable qualities such as their small size (12-16 kDa), their ability to refold after being chemically or thermally denatured and retain their antigen-binding capability, their propensity to bind cryptic epitopes not accessible to conventional antibodies and their relative ease of expression and purification using Escherichia coli expression systems (Hamerscasterman et al., 1993; Greenberg et al., 1995; Harmsen and Haard, 2007; de Marco, 2011; Eyer and Hruska, 2012; Griffiths et al., 2013) . These properties, along with the selectivity and sensitivity shared with conventional antibodies, make sdAbs especially amenable to a variety of rugged, field-portable diagnostic devices as well as therapeutic applications (Wesolowski et al., 2009; de Marco, 2011) . To that end, engineering sdAbs with increased thermal stability is an integral step in developing analytical platforms which are portable and capable of detection in adverse conditions and in locations where proper storage conditions may not be available.
Several strategies exist for improving the thermal stability of antibodies. The most common of these is the introduction of disulfide bonds at rationally defined locations within the secondary structure (Hagihara et al., 2007; Saerens et al., 2008; Hussack et al., 2011) . In addition, complementarity determining region (CDR) grafting onto stable frameworks has been explored (Jung and Plückthun, 1997; Ewert et al., 2004; Saerens et al., 2005) . DNA shuffling approaches have also been utilized (Maynard et al., 2002; Harmsen et al., 2006) . Another approach is the construction of random mutagenesis gene libraries followed by phage display and panning at appropriately stringent conditions. These conditions can include either heating or addition of denaturants during the panning process, or a combination of these. While this approach has been employed with conventional antibodies (McConnell et al., 2013) , their scFv derivatives (Wörn and Plückthun, 2001; Brockmann et al., 2005) and human-derived sdAbs (Jespers et al., 2004; Famm et al., 2008) to our knowledge, it has thus far not been applied to camelid sdAbs. In this work, we sought to use this approach to further increase the thermal stability of a previously isolated sdAb, referred to as A3, which binds to Staphylococcal enterotoxin B (SEB) (Graef et al., 2011; Anderson et al., 2012) . This sdAb not only possess a high affinity for SEB, but it also has an exceptionally high melting point of 83.58C; among the highest reported to date. Thus, our goal was to push the limits of this technique to enhance melting points and additionally to push the limits of sdAb thermal stability.
SEB, in addition to being the toxin most associated with food poisoning, is also a potential biological weapons agent. SEB can withstand temperatures exceeding 1008C and remain a potent toxin even after eradication of the originating bacteria (Ahanotu et al., 2006) . As a result of its stability, SEB is also easily transported and readily aerosolized and capable of causing mass illness even in small amounts (Ahanotu et al., 2006) . For these reasons, the development of platforms capable of the sensitive detection of SEB is of interest to the food industry as well as for defense applications. Thus, improving the stability of A3 would result in a detection reagent that would be even more amenable for use in a field-portable assay platform that could be forward deployed to locations where refrigerated storage is unavailable. The development of a stabilized sdAb as a recognition element of SEB would be a vital step in realizing such a platform, as well as provide insights into stabilizing mutations which could potentially be applied to other sdAb scaffolds.
Materials and methods

Random mutagenesis of A3-ds gene in pECAN21
Beginning with the gene for SEB-binding sdAb A3 in the phage vector pECAN21 (Goldman et al., 2006; Graef et al., 2011) , the disulfide bond present in A3 was removed by sitedirected mutagenesis polymerase chain reaction (PCR). This was accomplished by mutating the cysteine at position 22 to an alanine and the cysteine at position 99 to a valine resulting in a cysteine-free A3 (A3-ds) (Fig. 1) . These particular mutations were chosen such that the native disulfide bond was removed with only minimal impact on binding affinity (Saerens et al., 2005) . Abolishing the disulfide bond reduced the melting temperature of A3 208C, which was necessary to enable stringent panning conditions that would not inhibit phage infectivity after panning. Following site-directed mutagenesis, sequencing results confirmed the removal of cysteines.
Using the A3-ds-pECAN21 plasmid from above, the A3-ds gene was amplified by PCR using primers (A3pet22F and A3pet22R) designed to insert the NcoI and NotI restriction sites on the 5 0 -and 3 0 -ends of A3-ds, respectively. This product was cloned into the corresponding restriction sites in vectors pECAN21 (for phage amplification) and pET22b (for periplasmic protein expression). These constructs were confirmed by DNA sequencing.
The GeneMorph II random mutagenesis kit (Agilent) was used to create a random mutagenesis library of A3-ds. The gene was amplified using 125 ng each of primers A3pet22F and A3pet22R and 500 ng of template A3-ds-pECAN21. The PCR temperature program consisted of denaturation at 958C for 30 s, primer annealing at 728C for 30 s and primer extension at 728C for 1 min for 30 cycles. The mutagenesis PCR product (A3-ds-mut) was purified using the QIAquick PCR purification kit (Qiagen), and subsequently used as a 'megaprimer' in a second PCR reaction to insert the mutated A3-ds gene products into the pECAN21 plasmid. Briefly, 500 ng of the 'megaprimer' PCR product as the insert and 100 ng of A3-ds-pECAN21 as the template were used in a second PCR reaction resulting in the A3-ds-mut library inserted into the pECAN21 vector. The temperature program for the 'megaprimer' PCR reaction consisted of a denaturation step at 948C for 30 s, primer annealing at 608C for 1 min and primer extension at 688C for 16 min for 30 cycles. The purified and A3-ds-mut library was then transformed into electrocompetent XL-1 Blue cells (Agilent Technologies). Representative clones from this transformation were sent for sequencing to verify the presence of random mutation within clones from the library.
Phage amplification
For all experiments, phage amplification was carried out in the same manner. A 100 ml culture in terrific broth (TB) containing 100 mg/ml ampicillin, 10 mg/ml tetracycline and 1% w/v glucose was inoculated with 100 ml of a thawed glycerol stock of XL-1 Blue cells containing the phage library and grown to an OD 600 of 0.5. Next, 10 ml of this culture was transferred to a fresh culture tube and infected with a 1 : 20 (cells : phage) ratio of M13K07 helper phage and incubated at 378C for 30 min. This culture was pelleted by centrifugation at 3000 g for 15 min and then resuspended in 1.0 ml of TB and then used to inoculate a 50 ml volume of TB containing 100 mg/ml ampicillin and 25 mg/ml kanamycin and grown overnight at 308C. The culture was pelleted by centrifugation at 3000 g for 15 min, and the phage-containing supernatant was transferred to a fresh bottle with the addition of 10 ml of phage precipitation buffer containing 2.5 M NaCl and 20% w/v polyethylene glycol and incubated on ice for 60 min. The resulting suspension was centrifuged at 15,000 g for 45 min to pellet the phage, and the supernatant was discarded. The phage pellet was resuspended in 2 ml of phosphate-buffered saline (PBS), filter sterilized and stored at 48C until use.
Stringent selection
To select for phage harboring, A3 mutants with enhanced stability, stringent selection and panning was performed. In this panning procedure, the antigen, SEB, was coated onto the wells of a Nunc MaxiSorp 96-well microtiter plate. Antigen coating was accomplished by dispensing 100 ml of 5 mg/ml SEB directly into wells and incubating overnight at 48C. The next day, the solution was removed and the wells were washed three times with PBS containing 0.05% v/v Tween-20 (PBST). Wells were then blocked with PBST containing 5% w/v low-fat powdered milk (MPBS) for 60 min at room temperature. After blocking, the solution was removed and replaced with 25 ml of fresh blocking solution and 75 ml of the phage library and incubated at stringent conditions for 2 h. Unbound phage was removed from each well and wells were washed 20 times with PBST followed by 20 times with PBS. Bound phage was eluted in 100 ml of 100 mM triethylamine and neutralized in an equal amount of 1 M Tris-HCl, pH 7.4. Two rounds of stringent panning were performed differing only in the stringent conditions used in the phage incubation step described above. In the first, incubation was carried out at 458C and in the second at 558C. Both rounds were carried out in the presence of 2 M guanidine-HCl. Eluted phage was tittered and used to infect XL-1 Blue cells to amplify the eluted phage. This library was used to amplify selected phage as described above for subsequent panning at more stringent conditions.
Monoclonal phage enzyme-linked immunosorbent assay
Individual clones were identified from panned libraries by monoclonal phage enzyme-linked immunosorbent assay (ELISA). Individual binder clones were selected from XL-1 Blue titer plates following each round of selection and grown overnight in wells of a 96-well culture plate in 100 ml TB containing 100 mg/ml ampicillin and 1% w/v glucose. A small inoculum, about 2 ml, of this overnight culture was used to inoculate identical wells on a second plate containing 200 ml of growing media. After growth at 378C for 60 min, 25 ml of TB containing 100 mg/ml ampicillin, 1% w/v glucose and 10 9 pfu of M13K07 helper phage was added to each well and incubated without shaking at 378C for 30 min, then grown with shaking for 60 min. Next, the plate was centrifuged at 1800 g for 10 min and the supernatant was removed and replaced by 200 ml of TB containing 100 mg/ml ampicillin and 50 mg/ml kanamycin and incubated overnight at 378C.The following day, the plate was again centrifuged at 1800 g for 10 min and the phage-containing supernatant was used for monoclonal ELISA.
Briefly, wells of a 96-well Nunc MaxiSorp plate were coated, washed and blocked as above with SEB at a concentration of 5 mg/ml. Following blocking of the wells, 10 ml of monoclonal phage from above was added to each well along with 90 ml of MPBS and incubated for 90 min at room temperature. The phage solution was then removed, and the wells were washed three times with PBST and three times with PBS. The secondary antibody, horseradish peroxidase (HRP)-conjugated anti-M13, was diluted (1 : 5000) in 100 ml MPBS and incubated in the wells for 90 min at room temperature. Following incubation, all wells were washed three times with PBST and three times with PBS. The ELISA was developed by adding 100 ml of HRP substrate (3,3 0 ,5,5 0 -tetramethylbenzidine) and incubating for 10 min at room temperature. Color development was stopped with 50 ml of 1 M sulfuric acid and the absorbance of the solution in each well was measured. The ELISA measurement was reported as the difference in absorbance at 450 and 650 nm. Plasmid DNA was isolated from positive mutants identified by ELISA and sequenced at Operon Biotechnology using the LacZ sequencing primer. Sequences were analyzed using BioEdit Sequence Alignment Software and compared with the wild-type A3 sequence to identify mutations.
Restoration of disulfide bond
For the mutant determined to have improved thermal stability, A3-T28I-S72I, the wild-type disulfide bond was restored. This was accomplished using the QuickChange II Site-Directed Mutagenesis kit (Agilent) to restore both wild-type cysteines. Mutagenesis primers A3-H2-CysA (5 0 -GCCTGCGTCTGAG CTGCACCGCAAGCGGTCG-3 0 ) and A3-H2-CysB (5 0 -CCG CAGTTTATTATTGCGCAGCCGATCTG-3 0 ), with the underlined sequence denoting a mutation to cysteine, and their reverse complements were used for mutagenesis. Mutagenesis was performed separately for each cysteine using 10 ng of template plasmid and 125 ng each of primer. The mutagenesis reaction was performed by denaturing the DNA at 958C for 30 s, annealing primers at 558 for 60 s and extending primers at 688C for 9 min for 30 cycles. Mutagenesis products were confirmed by sequencing at Operon Biotechnologies using the T7 sequencing primer.
Restoration of single mutants in A3-T28I-S72I
A3-T28I-S72I, contained two mutations, T28I and S72I. To determine the contribution of each mutation to the improved stability, two additional mutants, A3-T28I and A3-S72I were constructed by site-directed mutagenesis as before. For restoration of mutants, primers A3-T28I (5 0 -ACCGCAAGCGGTCG TACCTTTAGCCGTGCAGTT-3 0 ) and A3-S72I (5 0 -GTGCG TGGTCGTTTTAGCATTAGCGCAGATAGC-3 0 ) and their reverse primers were used. For these mutagenesis reactions, 10 ng of template DNA and 125 ng of each primer were used. The mutagenesis reaction was performed using the temperature program above, except the annealing temperature was changed to 608C.
Protein expression in pET22b/Rosetta(DE3)
For expression of sdAbs of interest, the A3 mutants were cut from the pECAN21 vector using NcoI-HF and NotI-HF restriction enzymes (New England Biolabs) and ligated into similarly cut pET22b expression plasmid using T4 DNA ligase (New England Biolabs). Ligated plasmid was transformed into chemically competent XL-1 Blue cells for maintenance. Following sequence confirmation of the ligated product, the expression plasmids were transformed into Rosetta(DE3) cells for protein expression. The expression was similar to that described previously (Walper et al., 2012) . Fifty milliliter cultures of a single clone were grown overnight at 378C in TB containing 100 mg/ml ampicillin and 35 mg/ml chloramphenicol. The following day, 500 ml of TB containing the same was inoculated with the overnight culture and grown at 308C for 3 h. Protein expression was induced by adding isopropyl b-D-1-thiogalactopyranoside at a final concentration of 500 mM. The induced culture was grown for 3 h, then pelleted by centrifugation at 3000 g for 15 min at 48C. The pelleted cells were resuspended in 14 ml of chilled osmotic shock buffer (100 mM Tris, 0.75 M sucrose, pH 7.5). To this, 2.8 mg of lysozyme was added followed by the addition of 28 ml of 1 mM ethylenediaminetetraacetic acid, dropwise with shaking. The lysate was centrifuged at 8000 g for 20 min, and the supernatant was added to a fresh tube containing 5.0 ml 10Â immobilized metal ion affinity chromatography (IMAC) buffer (0.2 M Na 2 HPO 4 , 4 M NaCl, 200 mM imidazole, pH 7.5), 0.5 ml Ni-NTA resin (GE Healthcare) and 250 ml 0.5 M MgCl 2 . This slurry was incubated overnight at 48C with mixing. The following day, the resin was washed with 1Â IMAC buffer, then eluted in 1.0 ml aliquots of elution buffer (1Â IMAC containing 500 mM imidazole). Protein-containing fractions were further purified by fast protein liquid chromotography (FPLC) using a G-75 Superdex column and eluted in FPLC buffer (PBS, 0.02% sodium azide).
Circular dichroism
Protein thermal stability and refolding was observed as previously described using a Jasco J-815 CD Spectrometer equipped with a PTC-423S Peltier for temperature control . Samples were prepared at a concentration of 0.02 mg/ml by dilution in water. Circular dichroism (CD) measurements were performed in a 1.0 cm quartz cuvette. Protein unfolding was monitored at 205 nm as the Stabilization of sdAb by random mutagenesis and selection temperature was scanned from 25 to 958C at a rate of 2.58C/ min. The data pitch was 1 nm, digital integration time was 8 s and the bandwidth was 1.0 nm. To monitor refolding, the temperature was scanned from 95 to 258C as well, with the same parameters.
Differential scanning calorimetry
For mutants with high thermal stability, characterization was performed by differential scanning calorimetry (DSC). For DSC (TA instruments Nano DSC), samples were prepared at a concentration of 1 mg/ml in saved FPLC buffer. The sample and reference solutions (FPLC buffer) were extensively degassed under vacuum and 700 ml of each was loaded into the corresponding cell. The temperature was scanned from 258C through 1108C at a rate of 18C/min after an equilibration period of 300 s. Following the forward temperature scan, a reverse temperature scan was also performed to return to the starting temperature. For each mutant, DSC scans were completed using triplicate samples of protein and the standard deviation of the triplicates is reported in Fig. 3 . DSC data were analyzed using TA Instruments NanoAnalyze Data Analysis software.
Surface plasmon resonance kinetics
Surface plasmon resonance (SPR) kinetics measurements were performed using the ProteON XPR36 (Bio-Rad) using methods similar to those described previously . For testing the kinetics of the A3 mutants, a GLC sensor chip was coated with SEB. For immobilization, proteins were diluted in 10 mM acetate buffer, pH 5.0, and attached to the chip following the standard EDC (1-ethyl-3-[3-dimethylaminopropyl]carbodiimide hydrochloride) coupling chemistry provided by the manufacturer. All experiments were performed at 258C. The binding kinetics of various mutants were tested by flowing six concentrations varying from 1000 to 0 nM at 100 ml/min for 120 s over the antigen-coated chip and then monitoring the dissociation for 600 s. The chip was regenerated using 50 mM glycine-HCl ( pH 2.5) with 0.05% sodium dodecyl sulfate for 36 s, prior to any additional testing. Data analysis was performed with ProteOn Manager 2.1 software, corrected by subtraction of the zero antibody concentration column as well as interspot corrected; the binding constants were determined using the software's Langmuir model.
Protein structure prediction
For prediction of the structure of A3 and A3-T28I-S72I, the sequence was submitted to the Robetta protein structure prediction server (Kim et al., 2004) . Secondary structural features and domains were first predicted using Ginzu protocol. Following this, the full protein structure was predicted by comparative modeling using PDB 4JVP as a template structure (Tarr et al., 2013) .
Results
Construction of random mutagenesis library
In this work, our goal was to exploit a random mutagenesis approach to further increase the thermal stability of an sdAb (A3) that was already exceptionally stable, possessing a melting temperature of 83.58C (Graef et al., 2011) . To that end, a random mutagenesis library was created using the A3-ds gene in the M13 phage-encoding plasmid pECAN21, such that the mutants were presented as a fusion to M13 protein pIII. The A3-ds construct lacks the two conserved disulfide bond forming cysteines found in sdAbs; their removal results in a lower melting temperature of 62.68C. The removal of the cysteines to lower the melting temperature was necessary so that subsequent phage panning could be performed at stringent enough conditions to abolish binding of wild-type A3 while still maintaining phage infectivity. Following identification of stabilizing mutations, the cysteines would be restored, thus regaining the increase in melting temperature imparted by the disulfide bond. Using the disulfide-free construct, a phage library containing random mutants of A3 was generated from XL-1 Blue cells containing 8 Â 10 6 mutants. DNA sequencing of 10 selected clones from the library resulted in 10 unique mutants with average mutation frequency of 5.8 mutations per gene.
Biopanning under stringent conditions
To identify mutants with increased thermal stability, we employed a biopanning protocol under stringent conditions including increased temperature and the presence of chemical denaturants. Preliminary tests confirmed that M13 phage retain infectivity up to 608C and at concentrations of guanidine up to 6 M (Jung et al., 1999) . Stringent panning conditions were determined by performing ELISA experiments using phage harboring A3-ds sdAb at various temperature and guanidine concentrations to determine conditions that were stringent enough to abolish A3-ds binding to the antigen, SEB. From these experiments, it was determined that one round of panning at 458C and 2 M guanidine-HCl followed by a second round at 558C and 2 M guanidine-HCl would be performed.
Monoclonal phage ELISA
Following each round of panning, individual colonies were selected for monoclonal phage ELISA. Mutants which exhibited binding to SEB by ELISA were sequenced. Approximately 50% of mutants were unique mutants free of frame shifts or mutations introducing amber stop codons. These mutants were selected for further analysis and cloned into an expression plasmid, pET22b. Of the 10 mutants identified, 4 did not produce soluble protein (Table I ). The 69.5 A3-ds-G26D 64.8 A3-ds-W36Q-A50T * A3-ds-G7R-A21S-A31T-S76G * A3-ds-A14V-D17N-A40T-A58V-W119Q * A3-ds-S25C-R31H-D102Y * Melting temperatures were determined by CD at a protein concentration of 20 mg/ml by dilution. CD was monitored at 205 nm in a temperature range of 25-958C at a scan rate of 2.58C/min. *, T m could not be determined since clones did not produce soluble protein.
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expression studies on one of these, A3-ds-G7R-A21S-A31T-S76G, showed that protein was being expressed in the insoluble fraction (data not shown). Attempts to produce soluble protein from these mutants were unsuccessful, thus they were not evaluated further.
Characterization of sdAb mutants
Following expression and purification of identified mutants, characterization to determine melting temperatures and binding affinities was performed. The melting temperature of two mutants, A3-ds-R18C and A3-ds-R27C, were approximately the same as the native A3-ds protein which had a melting temperature of 62.68C (Table I) . Two other mutants, A3-ds-S88N
and A3-ds-G26D, had melting temperatures improved by 28C. One mutant, A3-ds-T28I-S72I (Fig. 1) , was significantly improved possessing a nearly 78C increase in melting temperature ( Fig. 2) with a melting temperature of 69.58C. The binding affinity of all disulfide-free mutants was determined by SPR and found to be similar to native A3-ds (data not shown). Because A3-ds-T28I-S72I demonstrated a large improvement in thermal stability, this mutant was the focus of subsequent characterization.
As the goal was not to enhance the stability of the disulfidefree form of A3, but to improve the melting point of wild-type A3, the wild-type cysteines were restored to A3-ds-T28I-S72I by site-directed mutagenesis resulting in A3-T28I-S72I (Fig. 1) . The melting temperature of both A3-T28I-S72I and wild-type A3 were determined by CD (Fig. 2) and later confirmed by DSC (Fig. 3) as the melting curve observed by CD was at the upper limit of the CD method. From the CD melting curve, it was clear that the melting temperature for A3-T28I-S72I was significantly higher than A3. DSC results confirmed this, determining a melting temperature of 90.08C for the mutant compared with 83.58C for the melting temperature of A3. In an effort to further elucidate the stability contributions of each mutation, both mutations were individually restored to their wild-type amino acids and the resulting single mutants, A3-T28I and A3-S72I were produced and characterized. Thermal stability of each single mutant was determined by DSC. The melting temperatures of A3-S72I and A3-T28I were determined to be 85.3 and 87.68C, respectively (Fig. 3) . This suggests that most of the increased stability of the double mutant results from the mutation at position 28. CD results also indicated that A3-T28I-S72I is able to partially refold upon cooling (Fig. 4) . Quantitative measurement of the degree of refolding was not possible from the CD data, as the proteins were not able to completely denature within the temperature limit of the CD experiment. In addition, the binding affinities of A3-ds, A3-T28I-S72I and each of the single mutants were determined by SPR, and found to be only minimally impacted, remaining similar to that for native A3 which has an affinity of 0.14 nM (Table II) . All binding affinities were determined to be sub-nanomolar differing from Fig. 3 . DSC scans of A3 (dotted curve), A3-S72I (hyphenated cure), A3-T28I (em dash curve) and A3-T28I-S72I (continuous curve). Scans were performed in triplicate at a scan rate of 18C/min at a protein concentration of 1.0 mg/ml in PBS with a final volume of 700 ml. The scan at the median melting temperature for each mutant is shown. Fig. 2 . Circular Dichroism (CD) protein stability data. A3-ds (white square), A3-ds-T28I-S72I (black square), A3 (white circle) and A3-T28I-S72I (black circle) were prepared at 20 mg/ml by dilution, and CD was monitored at 205 nm throughout temperature range of 25-958C at a rate of 2.58C/min. Fig. 4 . Circular Dichroism (CD) melting curve for A3-T28I-S72I. CD melting experiments were performed using 3.0 ml of protein at a concentration of 0.02 mg/ml in water. The temperature was ramped across the range shown at a rate of 2.58C/min in the forward direction (black circle) and reverse direction (white circle) as the CD at 205 nm was measured.
Stabilization of sdAb by random mutagenesis and selection one another by ,0.5 nM; all possessing extremely low off rates which made the discrimination of small differences by SPR problematic.
To investigate the effect of the stabilizing mutations on the potential for protein aggregation, the OD at 280 nm and binding activity was measured after heating solutions containing 1.0 mg/ml of each antibody to various temperatures both below and above their melting temperatures. Both A3 and A3-T28I-S73I resisted aggregation at temperatures below their respective melting temperatures (Fig. 5) . However, the increased thermal stability of A3-T28I-S72I allowed it to remain in solution upon heating to 858C while wild-type A3 aggregated over 50%. Somewhat unexpectedly, at temperatures in excess of its melting temperature, A3-T28I-S72I undergoes nearly complete aggregation while wild-type A3 never suffers more than 60% total aggregation. Activity determination by SPR of these samples demonstrates that the binding activity for both wild-type A3 and A3-T28I-S72I drops to below 50% upon heating above their respective melting temperatures. As a result, A3-T28I-S72I retains a majority of its binding activity at 858C, whereas wild-type A3 does not. Similar results were observed when this experiment was conducted at 0.1 mg/ml, however, with less aggregation (data not shown). These results are in line with previous reports that describe sdAbs that show partial refolding by CD, but lose binding activity in the heated sample (Dumoulin et al., 2002) .
Structural analysis of A3-T28I-S72I mutant
In an effort to understand the structural changes that may be contributing to increased stability in A3-T28I-S72I, the structure of wild-type A3 and A3-T28I-S72I was predicted using the Robetta protein structure prediction server by comparative modeling. The predicted structure matched closely to a typical sdAb V HH domain. In the predicted structure, there was no significant difference in the position or environment around the S72I mutation between the A3 and the mutant. However, in the predicted structure for A3, a void is located within the protein in the vicinity of T28 (Fig. 6) . In A3, T28 is directed outward from the protein surface. However, in the mutant, I28 is directed inside the protein into this cavity. In addition, other amino acids in the vicinity are directed towards I28, resulting in more favorable packing at this location and filling the void present in A3. This improved packing would likely have a stabilizing effect on the protein. These model predictions may explain our DSC results, as this individual mutation contributed most of the increase in the melting temperature.
Discussion
Improving the ruggedness and stability of sdAbs is vital to their successful application both as detection biomolecules and as therapeutics. While many sdAbs already exhibit refolding ability as well as elevated melting temperature, we sought Binding affinities were determined by flowing each sdAb over a GLC SPR chip coated with SEB. Antibodies were flowed over the chip at varying concentrations from 0 to 1000 nM at 120 ml/min for 120 s. Dissociation was then monitored for 600 s. Data analysis was performed by using ProteOn Manager software. . Solubility and activity study of A3 and A3-T28I-S72I. Samples were prepared at a concentration of 1.0 mg/ml and incubated at various temperatures for 5 min then cooled to room temperature and centrifuged to pellet any precipitate. The OD 280 for each was measured, as well as binding activity by SPR as described previously. to engineer an already stable sdAb to further improve these properties. Many approaches have been demonstrated for improving the stability of conventional antibodies and other proteins, from the introduction of disulfide bonds or other rational design approaches to more randomized approaches such as DNA shuffling or random mutagenesis. In this work, we used random mutagenesis in order to simultaneously identify a position in the structure of an sdAb as well as specific mutations which could improve thermal stability. Through random mutagenesis of an SEB-binding sdAb, A3, coupled with stringent selection of a phage display library, we have isolated mutants of A3 with improved thermal stability. One mutant, A3-T28I-S72I, possessed a melting temperature increased to 908C. Further characterization of this mutant, as well as single mutants A3-T28I and A3-S72I revealed that much of the increased stability results from the T28I mutation with only a small contribution from the S72I mutation. The T28I change is located within the CDR1 of the sdAb; it has been shown that the CDR regions of sdAbs can contribute to sdAb stability (Perchiacca et al., 2012; Zabetakis et al., 2013) . Characterization of the binding affinity of the mutants demonstrated that the mutations had no significant effect on the binding affinity of the antibody. In addition, we demonstrated that the mutant partially refolds upon cooling after heat denaturation. Also, it was shown that, as a result of increased thermal stability, A3-T28I-S72I both resists aggregation and maintains greater binding activity at an increased temperature compared with A3. To our knowledge, this is the first application of this strategy for increasing the thermal stability of a camelid sdAb.
As demonstrated, pursuing further stabilization of an sdAb that already contains stabilizing features such as a disulfide bond can be accomplished. It has been shown that packing of amino acids, especially near the outer surface of the protein where the void in A3 is located, can have a significant effect on stability (Glyakina et al., 2007) . In our random mutagenesis approach, we were able to identify a cavity within in the structure of the protein that was reducing its thermal stability by several degrees, as well as simultaneously identify a stabilizing mutation that drastically improved the packing in the vicinity of the cavity. In doing so, we have engineered an sdAb with a melting temperature among the highest observed while maintaining the protein's binding affinity.
